Difference between revisions of "DZI20-193"
From MGH Learn Pathology
(Updating subject, access, and performer) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | {{ | + | {{ServiceRequest |
| − | + | |intent=order | |
| − | | | + | |category=409073007 |
| − | | | + | |priority=routine |
| − | | | + | |orderDetail=order |
| − | | | + | |locationCode=learn |
| − | | | + | |code=study |
| − | | | + | |requisition=Frozen Conference |
| − | | | + | |supportingInfo=Breast |
| − | | | + | |reasonCode=Breast lymph nodes |
| − | | | + | |subject=MGH |
| − | + | |performer=MJF79 | |
| − | | | + | |authoredOn=October 16, 2020 01:39:50 PM |
| − | | | + | |requester=Em99 |
| − | + | |access=public | |
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | | | ||
| − | | | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}} | }} | ||
| + | {{status | ||
| + | |status=completed | ||
| + | |authoredOn=March 09, 2022 01:47:05 PM | ||
| + | |requester=Si787 | ||
| + | |identifier=DZI20-193 | ||
}} | }} | ||
Latest revision as of 15:16, June 21, 2022
Request details
- Request type Study
- Subspecialty Breast
- Set Frozen Conference
- Topic Breast lymph nodes
- Presenter Fitzpatrick, Megan Johnson
Toggle columns: Diagnosis
| Case | Clinical history | Requester | Diagnosis |
|---|---|---|---|
| Case | Clinical history | Requester | Diagnosis |
|
| 41 yo F with poorly differentiated adenocarcinoma | Mjf79 | At least one metastatic focus (0.1 cm). |
|
| 45 yo F with invasive mammary carcinoma • residual invasive mammary and DCIS on final | Mjf79 | positive for scattered carcinoma cells |
|
| 58 yo F with IDC grade 2 | Mjf79 | Rare atypical cells • consistent with metastatic carcinoma |
|
| 59 yo F with IDC grade 2 | Mjf79 | 2nd slide) Scattered malignant cells within fibrosis spanning approximately 5 cm in 1/1. 1st slide) Metastatic carcinoma spanning approximately 5 cm in 1/1 lymph node. |
|
| 59 yo with low to intermediate grade IDC | Mjf79 | Metastatic adenocarcinoma. |
|
| 45 yo F with metastatic carcinoma with lobular features (final ILC grade 2) | Mjf79 | Metastatic lobular carcinoma in 2 lymph nodes. |
|
| 48 yo F with invasive mammary carcinoma • provisional grade 2 (final IDC grade 2) | Mjf79 | 1 lymph node positive for metastatic carcinoma |
|
| 65 yo F with IDC grade 1 | Mjf79 | Metastatic carcinoma in 1 lymph node • macro metastasis |
|
| 47 yo F with invasive and in-situ mammary carcinoma • grade 2 (final IDC) | Mjf79 | Metastatic lobular carcinoma in 1 lymph node with deposits of approximately 4 mm and 3 mm. |
|
| 46 yo with IDC grade 2 | Mjf79 | 2 lymph nodes with treatment effect and scattered atypical cells • most consistent with metastatic carcinoma. |
|
| 46 yo IDC grade 2 | Mjf79 | Positive for metastatic carcinoma (1.3 cm on final) |
|
| 38 yo IDC grade 3 | Mjf79 | Metastatic carcinoma in 1 lymph node (1/1) (multiple foci spanning 0.5 cm). |
|
| 43 yo IDC • micropapillary type • grade 2 | Mjf79 | One lymph node positive for metastatic carcinoma (0.5 cm on final) |
|
| 44 yo with ILC • pleomorphic type • grade 2 to 3 | Mjf79 | Metastatic carcinoma in 1 lymph node. |
|
| 69 yo with DCIS grade 3 on core and final | Mjf79 | Small clusters of metastatic carcinoma • multifocal (<0.1.cm) in 1 lymph node. (present as several small clusters spanning 0.2 cm on final) |
|
| 39 yo F with IDC | Mjf79 | Metastatic carcinoma in 2 lymph nodes (1.4 cm) |
